Lisa M. Landrum, MD
Assistant Professor
The University of Oklahoma
Stephenson Cancer Center
800 NE 10th Street
Oklahoma City,
OK
USA
73104
Papers:
6
Clinical implications for MSI, MLH1 methylation analysis and IHC in Lynch screening for endometrial cancer patients: an analysis of 940 endometrioid endometrial cancer cases from the GOG0210 study
24
Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: an NRG Oncology/Gynecologic Oncology Group study
51
A Phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: a Gynecologic Oncology Group study
116
Provision of primary palliative care by gynecologic oncologists
486
Identifying gynecologic oncology patients with high symptom burden